Medtronic plc (MDT)
| Market Cap | 126.25B |
| Revenue (ttm) | 34.20B |
| Net Income (ttm) | 4.66B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.62 |
| PE Ratio | 27.19 |
| Forward PE | 17.17 |
| Dividend | $2.84 (2.91%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 8,134,545 |
| Open | 97.64 |
| Previous Close | 97.70 |
| Day's Range | 97.63 - 98.66 |
| 52-Week Range | 79.29 - 98.66 |
| Beta | 0.79 |
| Analysts | Buy |
| Price Target | 102.62 (+4.26%) |
| Earnings Date | Nov 18, 2025 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $102.62, which is an increase of 4.26% from the latest price.
News
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...
Medtronic: FY26 Outlook Strengthened By New Product Launches
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Medtronic plc (NYSE:MDT) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g...
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...
Medtronic: Buy This Dividend Aristocrat While It's Good Value
Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% re...
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offe...
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALW...
Medtronic Plc (MDT) Presents At Deutsche Bank Healthcare Summit Transcript
Medtronic plc (NYSE:MDT) Deutsche Bank Healthcare Summit September 10, 2025 12:00 PM EDT Company Participants Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Presen...
Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Medtronic plc (NYSE:MDT) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Thierry Pieton - Executive VP & CFO Conference Call Participants Pa...
Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Medtronic plc (NYSE:MDT) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive...
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. ,...
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
GALWAY, Ireland , Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones t...
Medtronic executives to speak at upcoming investor conferences
GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Well...
Why Medtronic Has Been Stuck for Over 1,100 Days And What Lies Ahead
Medtronic MDT has been trapped in a tight consolidation band for what feels like forever. For more than 1,100 days, the stock has stubbornly stayed between $75 and $95, showing little sign of life.
Best Dividend Aristocrats For September 2025
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...
Medtronic makes two key additions to its board. How activist Elliott can build shareholder value
The stage seems to be set for a long-term mutually beneficial relationship between the parties.
Medtronic: Earnings Are Solid, New Board Additions Add Intrigue
Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involve...
Medtronic Has Potential To Pursue Further Divestitures: Analyst
On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings
Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effect...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.
Activist investor Elliott push spurs changes at Medtronic
Medical device maker Medtronic is making changes to its board after Elliott Investment Management became one of its largest shareholders. CNBC's David Faber breaks down the details.
Medtronic plc (MDT) Q1 2026 Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q1 2026 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Geoffrey Straub Martha - Chairman of the Board & CEO Michael Marinaro - Executive VP & Presid...
Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway.
Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.